Development and validation of a blood biomarker risk prediction model for postmenopausal endometrioid endometrial cancer - Poll - MDSpire

Development and validation of a blood biomarker risk prediction model for postmenopausal endometrioid endometrial cancer

  • By

  • Hubin Xu

  • Mengyu Zhang

  • Huinan Zhu

  • Haimin Jiang

  • Wenjie Zeng

  • Xiaoyan Chen

  • Huafeng Shou

  • Lingqian Zhao

  • July 3, 2026

  • 0 min

Share

Original Source(s)

Development and validation of a blood biomarker risk prediction model for postmenopausal endometrioid endometrial cancer

  • by Hubin Xu, Mengyu Zhang, Huinan Zhu, Haimin Jiang, Wenjie Zeng, Xiaoyan Chen, Huafeng Shou, Lingqian Zhao

  • July 3, 2026

Related Content

Initial experience with the Carina™ platform for gasless transaxillary robotic thyroidectomy in papillary thyroid carcinoma: an early feasibility report

Gamma knife radiosurgery for renal cell carcinoma brain metastases across systemic therapy eras: survival, intracranial failure, and lesion-level predictors

A super-elderly patient with distal biliary tract cancer and tumor-associated granuloma: a case report